CM Hospitalar S/A (VVEO3) Earnings Call Transcripts
CM Hospitalar S/A's Latest Earnings Call - Q1 FY2026
In Q1 2026, CM Hospitalar S/A (VVEO3:BR) reported a net revenue of BRL 2.8 billion, marking a 1.7% increase YoY, aligning with their strategic shift towards selectivity in business engagements. The gross margin improved to 15.8%, reflecting a focus on higher-margin segments. Adjusted EBITDA rose by over 30% to BRL 208 million, highlighting operational efficiency. Management did not provide specific forward guidance but emphasized continued focus on cash generation and leverage reduction.
Reported metrics
| Metric | Value |
|---|---|
| Net Revenue | BRL 2.8 billion (inline) |
| Gross Margin | 15.8% (beat) |
| Adjusted EBITDA | BRL 208 million (beat) |
| Net Debt to EBITDA | 3.88x (beat) |
| Cash Generation | BRL 45 million (beat) |
Guidance from management
Management did not provide specific numerical guidance but emphasized continued focus on improving profitability, cash generation, and reducing leverage.
What management said
Thank you very much for attending. The company will continue on this trajectory of focus, simplification, selectiveness and certainly transformation of its culture and its organizational structure. Thank you very much for attending, and have a great day.
What analysts pressed on
Analysts questioned the seasonality of the cash cycle and the competitive environment. There is concern about how these factors might impact future cash generation and margin sustainability.
Main topics on the call
- Executive Board Restructuring — The company simplified its executive structure by removing three vice presidencies, aiming for a more integrated decision-making process. 'This integrated operation model is very important for us at this point in time,' ...
- Revenue Growth Strategy — Net revenue increased by 1.7% YoY to BRL 2.8 billion, driven by strategic selectiveness in business engagements. Management emphasized moving away from low-margin contracts.
- Gross Margin Improvement — Gross margin expanded by 2 percentage points, attributed to better pricing strategies and a shift towards higher-margin segments. 'We are now running our Consumer business with structurally higher margins,' noted CFO Fre...
- Cash Flow and Leverage — The company generated BRL 45 million in cash despite typical Q1 challenges, reducing leverage to 3.88x net debt over EBITDA. This reflects effective working capital management.
Read the full CM Hospitalar S/A transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About CM Hospitalar S/A
CM Hospitalar S/A (VVEO3) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on BOVESPA and is based in BR. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 4 calls on record spanning March 28, 2025 to May 15, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 4 CM Hospitalar S/A earnings call transcripts on record, spanning March 28, 2025 to May 15, 2026. Based on this history, CM Hospitalar S/A reports semi-annually. The most recent call on file is dated May 15, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- VVEO3
- Exchange
- BOVESPA
- Country
- BR
- Sector
- Health Care
- Calls on record
- 4
- First call
- March 28, 2025
- Most recent
- May 15, 2026
- Reporting cadence
- semi-annually
| Quarter | Date | |
|---|---|---|
| Q1 FY2026 | May 15, 2026 | Read transcript → |
| Q4 FY2025 | Mar 6, 2026 | Read transcript → |
| Q1 FY2025 | May 14, 2025 | Read transcript → |
| Q4 FY2024 | Mar 28, 2025 | Read transcript → |